Insiders · TALS

TALS insider transactions

Talaris Therapeutics Inc. (TALS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TALS

• 854d
  Mcdade Mark bought $3,250,000 worth of shares (100,000 units at $32.50) (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 901d
  SEC Form 4 filed by Siegall Clay B

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 901d
  SEC Form 3 filed by new insider Siegall Clay B

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 925d
  Kulkarni Sandeep Chidambar bought $67,960 worth of shares (4,000 units at $16.99), increasing direct ownership by 0.55% to 729,735 units (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 925d
  Thiara Parvinder bought $17,310 worth of shares (1,000 units at $17.31), increasing direct ownership by 1% to 83,782 units (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 950d
  Castelein Caley bought $280,584 worth of shares (20,000 units at $14.03), increasing direct ownership by 4% to 516,519 units (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Thiara Parvinder was granted 75,782 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Srivastava Sapna was granted 518 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  SEC Form 4 filed by Robinson Ryan F.

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Middlekauff W Bradford was granted 69,201 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Mcdade Mark was granted 348,949 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Kulkarni Sandeep Chidambar was granted 716,085 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Kantoff Aaron was granted 37,891 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Jones Susan Dana was granted 22,934 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Johnson Kevin Bruce was granted 57,834 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Chyung Yung H. was granted 56,836 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 953d
  Castelein Caley was granted 954,558 shares (SEC Form 4)

  4 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Thiara Parvinder

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Robinson Ryan F.

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Middlekauff W Bradford

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Kulkarni Sandeep Chidambar

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Kantoff Aaron

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Jones Susan Dana

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Johnson Kevin Bruce

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Chyung Yung H.

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Chester Cariad

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 954d
  SEC Form 3 filed by new insider Castelein Caley

  3 - Tourmaline Bio, Inc. (0001827506) (Issuer)
• 1063d
  SEC Form 4 filed by Fenton Mary Kay

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1063d
  SEC Form 4 filed by Requadt Scott

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Srivastava Sapna

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Smith Karen L.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Shah Gaurav

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Nader Francois

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Mcdade Mark

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Mackay Geoffrey

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1084d
  SEC Form 4 filed by Agarwala Sandip

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1090d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1092d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1094d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1135d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1139d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1141d
  SEC Form 4 filed by Ildstad Suzanne

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1153d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1153d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1153d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1153d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1153d
  SEC Form 4 filed by Ildstad Suzanne (Amendment)

  4/A - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1171d
  SEC Form 4 filed by Talaris Therapeutics Inc.

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1184d
  SEC Form 4: Ildstad Suzanne sold $13,992 worth of shares (6,806 units at $2.06), decreasing direct ownership by 0.22% to 3,064,560 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1189d
  SEC Form 4: Ildstad Suzanne sold $59 worth of shares (29 units at $2.05), decreasing direct ownership by 0.00% to 3,071,366 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1196d
  SEC Form 4: Ildstad Suzanne sold $7,185 worth of shares (3,500 units at $2.05), decreasing direct ownership by 0.11% to 3,071,395 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1198d
  SEC Form 4: Ildstad Suzanne sold $13,446 worth of shares (6,551 units at $2.05), decreasing direct ownership by 0.21% to 3,074,895 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1216d
  SEC Form 4 filed by Zdanowski Michael

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1216d
  SEC Form 4: Requadt Scott was granted 4 shares, increasing direct ownership by 0.00% to 590,193 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1216d
  SEC Form 4 filed by Krieger Nancy

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1216d
  SEC Form 4 filed by Fenton Mary Kay

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1359d
  SEC Form 4: Zdanowski Michael was granted 120,000 shares, increasing direct ownership by 8,163% to 121,470 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1359d
  SEC Form 4: Requadt Scott was granted 80,000 shares, increasing direct ownership by 16% to 590,189 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)
• 1359d
  SEC Form 4: Krieger Nancy was granted 80,000 shares, increasing direct ownership by 32% to 330,233 units

  4 - Talaris Therapeutics, Inc. (0001827506) (Issuer)